Cargando…
A multi-omics study of circulating phospholipid markers of blood pressure
High-throughput techniques allow us to measure a wide-range of phospholipids which can provide insight into the mechanisms of hypertension. We aimed to conduct an in-depth multi-omics study of various phospholipids with systolic blood pressure (SBP) and diastolic blood pressure (DBP). The associatio...
Autores principales: | , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8755711/ https://www.ncbi.nlm.nih.gov/pubmed/35022422 http://dx.doi.org/10.1038/s41598-021-04446-7 |
_version_ | 1784632427452301312 |
---|---|
author | Liu, Jun de Vries, Paul S. Del Greco M., Fabiola Johansson, Åsa Schraut, Katharina E. Hayward, Caroline van Dijk, Ko Willems Franco, Oscar. H. Hicks, Andrew A. Vitart, Veronique Rudan, Igor Campbell, Harry Polašek, Ozren Pramstaller, Peter P. Wilson, James F. Gyllensten, Ulf van Duijn, Cornelia M. Dehghan, Abbas Demirkan, Ayşe |
author_facet | Liu, Jun de Vries, Paul S. Del Greco M., Fabiola Johansson, Åsa Schraut, Katharina E. Hayward, Caroline van Dijk, Ko Willems Franco, Oscar. H. Hicks, Andrew A. Vitart, Veronique Rudan, Igor Campbell, Harry Polašek, Ozren Pramstaller, Peter P. Wilson, James F. Gyllensten, Ulf van Duijn, Cornelia M. Dehghan, Abbas Demirkan, Ayşe |
author_sort | Liu, Jun |
collection | PubMed |
description | High-throughput techniques allow us to measure a wide-range of phospholipids which can provide insight into the mechanisms of hypertension. We aimed to conduct an in-depth multi-omics study of various phospholipids with systolic blood pressure (SBP) and diastolic blood pressure (DBP). The associations of blood pressure and 151 plasma phospholipids measured by electrospray ionization tandem mass spectrometry were performed by linear regression in five European cohorts (n = 2786 in discovery and n = 1185 in replication). We further explored the blood pressure-related phospholipids in Erasmus Rucphen Family (ERF) study by associating them with multiple cardiometabolic traits (linear regression) and predicting incident hypertension (Cox regression). Mendelian Randomization (MR) and phenome-wide association study (Phewas) were also explored to further investigate these association results. We identified six phosphatidylethanolamines (PE 38:3, PE 38:4, PE 38:6, PE 40:4, PE 40:5 and PE 40:6) and two phosphatidylcholines (PC 32:1 and PC 40:5) which together predicted incident hypertension with an area under the ROC curve (AUC) of 0.61. The identified eight phospholipids are strongly associated with triglycerides, obesity related traits (e.g. waist, waist-hip ratio, total fat percentage, body mass index, lipid-lowering medication, and leptin), diabetes related traits (e.g. glucose, insulin resistance and insulin) and prevalent type 2 diabetes. The genetic determinants of these phospholipids also associated with many lipoproteins, heart rate, pulse rate and blood cell counts. No significant association was identified by bi-directional MR approach. We identified eight blood pressure-related circulating phospholipids that have a predictive value for incident hypertension. Our cross-omics analyses show that phospholipid metabolites in the circulation may yield insight into blood pressure regulation and raise a number of testable hypothesis for future research. |
format | Online Article Text |
id | pubmed-8755711 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Nature Publishing Group UK |
record_format | MEDLINE/PubMed |
spelling | pubmed-87557112022-01-13 A multi-omics study of circulating phospholipid markers of blood pressure Liu, Jun de Vries, Paul S. Del Greco M., Fabiola Johansson, Åsa Schraut, Katharina E. Hayward, Caroline van Dijk, Ko Willems Franco, Oscar. H. Hicks, Andrew A. Vitart, Veronique Rudan, Igor Campbell, Harry Polašek, Ozren Pramstaller, Peter P. Wilson, James F. Gyllensten, Ulf van Duijn, Cornelia M. Dehghan, Abbas Demirkan, Ayşe Sci Rep Article High-throughput techniques allow us to measure a wide-range of phospholipids which can provide insight into the mechanisms of hypertension. We aimed to conduct an in-depth multi-omics study of various phospholipids with systolic blood pressure (SBP) and diastolic blood pressure (DBP). The associations of blood pressure and 151 plasma phospholipids measured by electrospray ionization tandem mass spectrometry were performed by linear regression in five European cohorts (n = 2786 in discovery and n = 1185 in replication). We further explored the blood pressure-related phospholipids in Erasmus Rucphen Family (ERF) study by associating them with multiple cardiometabolic traits (linear regression) and predicting incident hypertension (Cox regression). Mendelian Randomization (MR) and phenome-wide association study (Phewas) were also explored to further investigate these association results. We identified six phosphatidylethanolamines (PE 38:3, PE 38:4, PE 38:6, PE 40:4, PE 40:5 and PE 40:6) and two phosphatidylcholines (PC 32:1 and PC 40:5) which together predicted incident hypertension with an area under the ROC curve (AUC) of 0.61. The identified eight phospholipids are strongly associated with triglycerides, obesity related traits (e.g. waist, waist-hip ratio, total fat percentage, body mass index, lipid-lowering medication, and leptin), diabetes related traits (e.g. glucose, insulin resistance and insulin) and prevalent type 2 diabetes. The genetic determinants of these phospholipids also associated with many lipoproteins, heart rate, pulse rate and blood cell counts. No significant association was identified by bi-directional MR approach. We identified eight blood pressure-related circulating phospholipids that have a predictive value for incident hypertension. Our cross-omics analyses show that phospholipid metabolites in the circulation may yield insight into blood pressure regulation and raise a number of testable hypothesis for future research. Nature Publishing Group UK 2022-01-12 /pmc/articles/PMC8755711/ /pubmed/35022422 http://dx.doi.org/10.1038/s41598-021-04446-7 Text en © Crown 2022 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Article Liu, Jun de Vries, Paul S. Del Greco M., Fabiola Johansson, Åsa Schraut, Katharina E. Hayward, Caroline van Dijk, Ko Willems Franco, Oscar. H. Hicks, Andrew A. Vitart, Veronique Rudan, Igor Campbell, Harry Polašek, Ozren Pramstaller, Peter P. Wilson, James F. Gyllensten, Ulf van Duijn, Cornelia M. Dehghan, Abbas Demirkan, Ayşe A multi-omics study of circulating phospholipid markers of blood pressure |
title | A multi-omics study of circulating phospholipid markers of blood pressure |
title_full | A multi-omics study of circulating phospholipid markers of blood pressure |
title_fullStr | A multi-omics study of circulating phospholipid markers of blood pressure |
title_full_unstemmed | A multi-omics study of circulating phospholipid markers of blood pressure |
title_short | A multi-omics study of circulating phospholipid markers of blood pressure |
title_sort | multi-omics study of circulating phospholipid markers of blood pressure |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8755711/ https://www.ncbi.nlm.nih.gov/pubmed/35022422 http://dx.doi.org/10.1038/s41598-021-04446-7 |
work_keys_str_mv | AT liujun amultiomicsstudyofcirculatingphospholipidmarkersofbloodpressure AT devriespauls amultiomicsstudyofcirculatingphospholipidmarkersofbloodpressure AT delgrecomfabiola amultiomicsstudyofcirculatingphospholipidmarkersofbloodpressure AT johanssonasa amultiomicsstudyofcirculatingphospholipidmarkersofbloodpressure AT schrautkatharinae amultiomicsstudyofcirculatingphospholipidmarkersofbloodpressure AT haywardcaroline amultiomicsstudyofcirculatingphospholipidmarkersofbloodpressure AT vandijkkowillems amultiomicsstudyofcirculatingphospholipidmarkersofbloodpressure AT francooscarh amultiomicsstudyofcirculatingphospholipidmarkersofbloodpressure AT hicksandrewa amultiomicsstudyofcirculatingphospholipidmarkersofbloodpressure AT vitartveronique amultiomicsstudyofcirculatingphospholipidmarkersofbloodpressure AT rudanigor amultiomicsstudyofcirculatingphospholipidmarkersofbloodpressure AT campbellharry amultiomicsstudyofcirculatingphospholipidmarkersofbloodpressure AT polasekozren amultiomicsstudyofcirculatingphospholipidmarkersofbloodpressure AT pramstallerpeterp amultiomicsstudyofcirculatingphospholipidmarkersofbloodpressure AT wilsonjamesf amultiomicsstudyofcirculatingphospholipidmarkersofbloodpressure AT gyllenstenulf amultiomicsstudyofcirculatingphospholipidmarkersofbloodpressure AT vanduijncorneliam amultiomicsstudyofcirculatingphospholipidmarkersofbloodpressure AT dehghanabbas amultiomicsstudyofcirculatingphospholipidmarkersofbloodpressure AT demirkanayse amultiomicsstudyofcirculatingphospholipidmarkersofbloodpressure AT liujun multiomicsstudyofcirculatingphospholipidmarkersofbloodpressure AT devriespauls multiomicsstudyofcirculatingphospholipidmarkersofbloodpressure AT delgrecomfabiola multiomicsstudyofcirculatingphospholipidmarkersofbloodpressure AT johanssonasa multiomicsstudyofcirculatingphospholipidmarkersofbloodpressure AT schrautkatharinae multiomicsstudyofcirculatingphospholipidmarkersofbloodpressure AT haywardcaroline multiomicsstudyofcirculatingphospholipidmarkersofbloodpressure AT vandijkkowillems multiomicsstudyofcirculatingphospholipidmarkersofbloodpressure AT francooscarh multiomicsstudyofcirculatingphospholipidmarkersofbloodpressure AT hicksandrewa multiomicsstudyofcirculatingphospholipidmarkersofbloodpressure AT vitartveronique multiomicsstudyofcirculatingphospholipidmarkersofbloodpressure AT rudanigor multiomicsstudyofcirculatingphospholipidmarkersofbloodpressure AT campbellharry multiomicsstudyofcirculatingphospholipidmarkersofbloodpressure AT polasekozren multiomicsstudyofcirculatingphospholipidmarkersofbloodpressure AT pramstallerpeterp multiomicsstudyofcirculatingphospholipidmarkersofbloodpressure AT wilsonjamesf multiomicsstudyofcirculatingphospholipidmarkersofbloodpressure AT gyllenstenulf multiomicsstudyofcirculatingphospholipidmarkersofbloodpressure AT vanduijncorneliam multiomicsstudyofcirculatingphospholipidmarkersofbloodpressure AT dehghanabbas multiomicsstudyofcirculatingphospholipidmarkersofbloodpressure AT demirkanayse multiomicsstudyofcirculatingphospholipidmarkersofbloodpressure |